<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104383">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02150161</url>
  </required_header>
  <id_info>
    <org_study_id>56csm2014001</org_study_id>
    <nct_id>NCT02150161</nct_id>
  </id_info>
  <brief_title>Opioid vs. Opioid-free Anesthesia for Hip Arthroscopy</brief_title>
  <official_title>Fentanyl vs. Lidocaine/Ketamine Infusion for Hip Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinica Santa Maria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinica Santa Maria</source>
  <oversight_info>
    <authority>Chile: Servicio de Salud Metropolitano Oriente</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether an infusion of lidocaine/ketamine compared
      to fentanyl is equivalent in anesthesia effectiveness and can help reduce the incidence of
      postoperative nausea and vomiting in patients undergoing elective hip arthroscopy surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Incidence of postoperative nausea and vomiting in the recovery room</measure>
    <time_frame>first 3 postoperative hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>morphine consumption in the recovery room</measure>
    <time_frame>first 3 postopeartive hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative nausea and vomiting  on day 1</measure>
    <time_frame>1st postoperative day</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthestic gas consumption</measure>
    <time_frame>intraoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Opioid Free Anaesthesia</condition>
  <condition>Postoperative Analgesia</condition>
  <arm_group>
    <arm_group_label>lidocaine/ ketamine infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lidocaine 1mg/Kg bolus, followed by continuous infusion 1 mg/kg/h AND ketamine 1mg/Kg bolus followed by continuous infusion 1 mg/kg/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>iv fentanyl, 3ug/kg bolus</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine/ ketamine</intervention_name>
    <arm_group_label>lidocaine/ ketamine infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <arm_group_label>fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 years old

          -  ASA I-II

          -  Undergoing elective hip arthroscopy

        Exclusion Criteria:

          -  Known allergies to study drugs

          -  Opioid use 1 month prior to surgery

          -  BMI &gt;30

          -  Unable to comprehend visual analog scale
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Torres, MD; MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Santa Maria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Torres, MD, MSc</last_name>
    <phone>+56 998716570</phone>
    <email>dtorresp@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinica Santa Maria</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Torres, MD, MSc</last_name>
      <email>dtorresp@gmail.com</email>
    </contact>
    <investigator>
      <last_name>David Torres</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>May 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinica Santa Maria</investigator_affiliation>
    <investigator_full_name>David Torres</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
